Page 43 of The Sterling Acquisition
The footage showed test animals following researchers like shadows, displaying distress when separated from specific handlers, and performing behaviors that would have been impossible before the treatment. The clinical notes beside each video catalogued the changes with detached scientific precision, as if the complete destruction of natural personality was merely an interesting data point.
Dante looked at the video files and felt sick, a cold sweat breaking out across his forehead. He’d seen countless examples of behavioral modification across territories, but nothing like this—nothing that so completely erased the original personality while leaving the subject believing they were still themselves.
“And Morrison wants to use untested technology on Leo’s Omega?” he asked, though it wasn’t really a question. His voice was flat, professional training kicking in to mask the growing fury beneath.
“Test Subject Number One,” Duckie confirmed, pulling up a new file that made Dante’s vision narrow to a tunnel, his peripheral awareness fading as he focused on the screen. “The first human trial. Morrison thinks using a virgin subject will provide the cleanest data—no previous bonding to complicate the artificial attachment process.”
There, on the screen, was Orion’s photograph alongside detailed medical information and psychological assessments. The image showed him glaring at the camera, eyes blazing with the same defiance Dante witnessed firsthand. The clinical assessments labeled this as “extreme resistance pathology” rather than the fierce independence Dante knew it to be.
Subject Profile: Test Subject #1
Age:26
Designation:Omega, Virgin, Unclaimed
Current Handler:Leo James, Research Associate
Resistance Level:Extreme
Recommended Protocol:Full Tether Implementation with Anchor/Link sequence
Treatment Protocol - Test Subject #1:
Hour 1: Initial sedation and baseline psychological mapping
Hour 2: Anchor serum administration (establishes biochemical receptivity)
Hour 4: Link catalyst injection with bonding initiation to Handler James
Hours 6-24: Monitoring for integration and adverse reactions
The rest of the file was marked with security restrictions that even Duckie couldn’t access.
Dante stared at Orion’s photograph, something primal and possessive twisting in him. The thought of Orion being strapped to one of those tables, pumped full of chemicals designed to make him adore Leo of all people, made his vision blur with rage. His hands were shaking, he realized distantly, a physical response he hadn’t experienced since his earliest training days.
Twenty years of Gensyn conditioning didn’t prepare him for this visceral reaction to seeing someone he—
What? Desired? That was certainly true, but incomplete. Respected? Also true, but still insufficient. The realization that he couldn’t categorize his feelings for Orion within standard corporate parameters was itself disturbing, a sign of how far he’d already strayed from his training.
“When is this scheduled?” Dante asked, his voice controlled despite the irregular pounding of his heart.
“Soon. Morrison’s been waiting for the right biological timing.” Duckie’s discomfort was obvious as he gestured toward a scheduling terminal across the lab. “An exact date is in Morrison’s private system if the Omega doesn’t hit a full heat soon, they’ll use an accelerant to make it happen. He keeps the timeline locked down with triple biometric security—retinal, voice, and DNA verification. He’s paranoid about corporate espionage, especially after what happened with the Chimera Syndicate leak last year.”
“Elaborate,” Dante said, moving toward the scheduling terminal.
“Morrison had another project—behavioral pheromone manipulation—that got leaked to Elysian. He lost months of research advantage, and three researchers were executed for industrial espionage. The SVI board denied knowing about it.” Duckie’s voice dropped even lower. “Since then, critical scheduling and implementation details are compartmentalized. I only know it’s happening soon because Morrison’s been having us prepare the holding cells and calibrate the delivery systems.”
Dante examined the terminal, confirming Duckie’s assessment. The security was beyond what he could bypass in a single visit without specialized equipment.
“I’ll need copies of what you can access,” Dante said. “The technical specifications, the treatment protocols you’ve shown me.”
“I can’t copy everything—the system logs data transfers, and Morrison monitors access to classified files.” Duckie hesitated. “But I could transfer some of the basic research, maybe a few key documents. Enough to demonstrate the technology without triggering security alerts.”
“Do it.”
Duckie began a selective transfer, his movements nervous. “Just... be careful with this information. If Morrison discovers there’s been unauthorized access...”
“Complete discretion,” Dante assured him. “Our clients understand the value of maintaining operational security.”
Table of Contents
- Page 1
- Page 2
- Page 3
- Page 4
- Page 5
- Page 6
- Page 7
- Page 8
- Page 9
- Page 10
- Page 11
- Page 12
- Page 13
- Page 14
- Page 15
- Page 16
- Page 17
- Page 18
- Page 19
- Page 20
- Page 21
- Page 22
- Page 23
- Page 24
- Page 25
- Page 26
- Page 27
- Page 28
- Page 29
- Page 30
- Page 31
- Page 32
- Page 33
- Page 34
- Page 35
- Page 36
- Page 37
- Page 38
- Page 39
- Page 40
- Page 41
- Page 42
- Page 43 (reading here)
- Page 44
- Page 45
- Page 46
- Page 47
- Page 48
- Page 49
- Page 50
- Page 51
- Page 52
- Page 53
- Page 54
- Page 55
- Page 56
- Page 57
- Page 58
- Page 59
- Page 60
- Page 61
- Page 62
- Page 63
- Page 64
- Page 65
- Page 66
- Page 67
- Page 68
- Page 69
- Page 70
- Page 71
- Page 72
- Page 73
- Page 74
- Page 75
- Page 76
- Page 77
- Page 78
- Page 79
- Page 80
- Page 81
- Page 82
- Page 83
- Page 84
- Page 85
- Page 86
- Page 87
- Page 88
- Page 89
- Page 90
- Page 91
- Page 92
- Page 93
- Page 94
- Page 95
- Page 96
- Page 97
- Page 98
- Page 99
- Page 100
- Page 101
- Page 102
- Page 103
- Page 104
- Page 105
- Page 106
- Page 107
- Page 108
- Page 109
- Page 110
- Page 111
- Page 112
- Page 113
- Page 114
- Page 115
- Page 116
- Page 117
- Page 118
- Page 119
- Page 120
- Page 121
- Page 122
- Page 123
- Page 124
- Page 125
- Page 126
- Page 127
- Page 128
- Page 129
- Page 130
- Page 131
- Page 132
- Page 133
- Page 134
- Page 135
- Page 136
- Page 137